All News #Library
Others
FTC requires Hikma to let go of steroid drug, post $375M Custopharm acquisition
20 Apr 2022 //
ENDPTS
Hikma`s $425M injectables buy will face FTC scrutiny
28 Sep 2021 //
FIERCEPHARMA

Market Place
Sourcing Support